Back to Work

Roger Perlmutter is to take the helm of Merck's research and development branch, the Wall Street Journal reports. Previously, Perlmutter was the executive vice president of research and development at Amgen until his retirement about a year ago and prior to joining Amgen he was worked in basic research at Merck. "By hiring Dr.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Star-studded Prize

Doing It Themselves

A Country's Risk

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.